Santanu Samanta
Concepts (63)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasm Recurrence, Local | 3 | 2024 | 639 | 0.360 |
Why?
| | Head and Neck Neoplasms | 2 | 2024 | 289 | 0.340 |
Why?
| | Brachytherapy | 1 | 2023 | 50 | 0.200 |
Why?
| | Graft vs Host Disease | 1 | 2023 | 91 | 0.190 |
Why?
| | Caveolin 1 | 1 | 2021 | 20 | 0.180 |
Why?
| | Hematologic Neoplasms | 1 | 2023 | 101 | 0.180 |
Why?
| | Radiation Tolerance | 1 | 2021 | 78 | 0.170 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2020 | 24 | 0.170 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2024 | 299 | 0.170 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 231 | 0.150 |
Why?
| | Substance-Related Disorders | 1 | 2024 | 615 | 0.140 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2023 | 600 | 0.140 |
Why?
| | Parasympathetic Fibers, Postganglionic | 1 | 2017 | 1 | 0.140 |
Why?
| | Prostate | 1 | 2017 | 116 | 0.130 |
Why?
| | Radiation Injuries, Experimental | 1 | 2017 | 80 | 0.130 |
Why?
| | Erectile Dysfunction | 1 | 2017 | 94 | 0.120 |
Why?
| | Lung Neoplasms | 1 | 2021 | 643 | 0.120 |
Why?
| | Retrospective Studies | 4 | 2024 | 6694 | 0.090 |
Why?
| | Prognosis | 2 | 2024 | 2100 | 0.070 |
Why?
| | Aged, 80 and over | 2 | 2024 | 3449 | 0.060 |
Why?
| | Humans | 7 | 2024 | 52441 | 0.060 |
Why?
| | Adult | 3 | 2024 | 14205 | 0.050 |
Why?
| | Radiotherapy Dosage | 1 | 2024 | 256 | 0.050 |
Why?
| | Vidarabine | 1 | 2023 | 9 | 0.050 |
Why?
| | Busulfan | 1 | 2023 | 18 | 0.050 |
Why?
| | Academic Medical Centers | 1 | 2024 | 151 | 0.050 |
Why?
| | Pain, Postoperative | 1 | 2024 | 169 | 0.050 |
Why?
| | Computer Simulation | 1 | 2023 | 285 | 0.050 |
Why?
| | Transplantation Conditioning | 1 | 2023 | 93 | 0.050 |
Why?
| | Radiotherapy, Intensity-Modulated | 1 | 2024 | 184 | 0.050 |
Why?
| | Whole-Body Irradiation | 1 | 2023 | 128 | 0.050 |
Why?
| | Protein Interaction Maps | 1 | 2021 | 28 | 0.050 |
Why?
| | Neoplasm Staging | 1 | 2024 | 768 | 0.050 |
Why?
| | Microarray Analysis | 1 | 2021 | 69 | 0.050 |
Why?
| | Gene Dosage | 1 | 2021 | 73 | 0.040 |
Why?
| | Mice, Nude | 1 | 2021 | 230 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2021 | 218 | 0.040 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2020 | 15 | 0.040 |
Why?
| | Mice, Inbred BALB C | 1 | 2021 | 304 | 0.040 |
Why?
| | Neoplastic Stem Cells | 1 | 2021 | 88 | 0.040 |
Why?
| | Neoplasm Invasiveness | 1 | 2021 | 278 | 0.040 |
Why?
| | DNA Repair | 1 | 2021 | 194 | 0.040 |
Why?
| | Aged | 2 | 2024 | 10242 | 0.040 |
Why?
| | Up-Regulation | 1 | 2021 | 462 | 0.040 |
Why?
| | Angiogenesis Inhibitors | 1 | 2020 | 183 | 0.040 |
Why?
| | Female | 3 | 2024 | 28277 | 0.040 |
Why?
| | Middle Aged | 2 | 2024 | 13133 | 0.040 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2021 | 331 | 0.040 |
Why?
| | Analgesics, Opioid | 1 | 2024 | 601 | 0.030 |
Why?
| | Male | 3 | 2024 | 26874 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2021 | 853 | 0.030 |
Why?
| | Penile Erection | 1 | 2017 | 25 | 0.030 |
Why?
| | Neural Conduction | 1 | 2017 | 34 | 0.030 |
Why?
| | Staining and Labeling | 1 | 2017 | 92 | 0.030 |
Why?
| | Penis | 1 | 2017 | 85 | 0.030 |
Why?
| | Random Allocation | 1 | 2017 | 286 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1099 | 0.030 |
Why?
| | Animals | 2 | 2021 | 13485 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2024 | 5508 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2017 | 1558 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2017 | 1483 | 0.020 |
Why?
| | Mice | 1 | 2021 | 5899 | 0.020 |
Why?
| | Rats | 1 | 2017 | 3228 | 0.020 |
Why?
|
|
Samanta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|